QualcommSemiconductor company Qualcomm lost ground on Monday despite activist firm Jana Partners urging it to speed up a $10 billion stock repurchase and consider splitting its business. The stock closed more than half a percent lower, around $69 per share.Trader Dan Nathan said that Qualcomm looked “broken.” He added that it would continue to be a “work in progress.”YahooInternet company […]
In the ongoing bad-news-is-good-news saga, last week’s surprisingly weak jobs report led to speculation that the Fed would delay hiking interest rates, which is perceived as a positive for equity investors. So, bulls are getting a boost for the moment, although those previously hard-won round-number price levels for the major indexes are now serving as ominous overhead resistance that will […]
Is The Stock Market On The Verge Of Collapse?March 31st, 2015Are we watching a replay of the last financial crisis? Over the past six months, the price of oil has collapsed, the U.S. dollar has soared, and a whole bunch of other patterns that we witnessed just before the stock market crash of 2008 are repeating once again. But what we have not […]
TraderFeed: New Highs and Lows in the Stock Market and What They Tell Us
New Highs and Lows in the Stock Market and What They Tell UsIf you’ve followed the blog for a while, you know that tracking the number of stocks across all exchanges making fresh one- and three-month new highs versus lows is one of my favorite measures of […]
Seymour warned that the fund sat in “overbought territory,” saying that it might soon pull back. Trader Brian Kelly agreed, adding that investors might want to take profits on biotech names next week.Some biotech names may not have exhausted their momentum, trader Guy Adami said. He believes that Celgene could move even higher, adding that Gilead and Amgen may have […]
No one likes the “B” word, but it’s worth asking whether we’re seeing one in large-cap biotech stocks right now.Source: ©iStock.com/AlexRathsAt first glance, it seems to be a legitimate question given how well the sector has performed in the past year. The iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) has gained nearly 70% since the low of mid-April 2014, and it […]
Eight of nine sectors moved higher on Monday…XLI, XLV and XLY were the strongest sectors andXLE was the weakest.Breadth strengthened as advancers led decliners 1.11 to 1 on the NYSE and weakened on the NASDAQ 1.24 to 1.Monday – strengthened, advancers ledSPY up .86 at 208.36 on 89.8 million shares, below average volumeVIX down .14 at 15.06…TNX down .45 at […]
Stock Trading Alert: More Uncertainty As Stocks Continue To Fluctuate Along Record LevelsBy: Paul Rejczak | Thu, Mar 5, 2015SharePrintEmailStock Trading Alert originally published on March 5, 2015, 6:20 AM:Briefly: In our opinion, speculative short positions are favored (with stop-loss at 2,150 and profit target at 1,980, S&P 500 index)Our intraday outlook is bearish, and our short-term outlook is bearish:Intraday […]
View photo.Biotech stocks have performed well in the recent bull market.Since January 1, 2008, the SPDR S&P Biotech ETF (NYSE: XBI) has outperformed the SPDR S&P 500 ETF Trust (NYSE: SPY), gaining 233 percent compared with just 41.3 percent gains in SPY.Analysts at Sterne Agee took a closer look at three active biotech companies in separate notes Friday morning.Molina Healthcare, […]
SummaryHot = near-term stock price gain potential, not just product developments, lab breakthroughs, corporate acquisitions, financing deals, trial progresses etc.
Only opinions; not even “just the facts, m’aam”. But opinions expressed by folks who need to know, willing to put their money at risk, based on what they know.
Maybe even better, ones who are willing to pay up for price-change risk […]
